Literature DB >> 14695942

Coenzyme Q differentially modulates phospholipid hydroperoxide glutathione peroxidase gene expression and free radicals production in malignant and non-malignant prostate cells.

J L Quiles1, A J Farquharson, M C Ramírez-Tortosa, I Grant, L Milne, J R Huertas, M Battino, J Mataix, K W J Wahle.   

Abstract

The aim of this study was to investigate the role of coenzyme Q on the mRNA abundance of PHGPx and the reactive oxygen species (ROS) production in two different cell lines from human prostate, a line of non cancer cells (PNT2) and a line of cancer cells (PC3). Results showed that malignant cells markedly differ in their response to coenzyme Q compared to non-malignant cells, with no changes in PHGPx expression and greater ROS production. Furthermore coenzyme Q supplementation significantly lowered cell growth of the PC3 cancer line without affecting the PNT2. If these results are confirmed with additional experiments, it could represent a novel and interesting approach on the biomedical use of coenzyme Q10 in cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14695942     DOI: 10.1002/biof.5520180229

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  4 in total

1.  Plasma coenzyme Q10 levels and prostate cancer risk: the multiethnic cohort study.

Authors:  Weiwen Chai; Robert V Cooney; Adrian A Franke; Christian P Caberto; Lynne R Wilkens; Loïc Le Marchand; Marc T Goodman; Brian E Henderson; Laurence N Kolonel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-02-04       Impact factor: 4.254

2.  Specialty supplements and prostate cancer risk in the VITamins and Lifestyle (VITAL) cohort.

Authors:  Theodore M Brasky; Alan R Kristal; Sandi L Navarro; Johanna W Lampe; Ulrike Peters; Ruth E Patterson; Emily White
Journal:  Nutr Cancer       Date:  2011       Impact factor: 2.900

3.  Effects of coenzyme Q10 supplementation on inflammation, angiogenesis, and oxidative stress in breast cancer patients: a systematic review and meta-analysis of randomized controlled- trials.

Authors:  Mina Alimohammadi; Ali Rahimi; Fatemeh Faramarzi; Monireh Golpour; Reza Jafari-Shakib; Reza Alizadeh-Navaei; Alireza Rafiei
Journal:  Inflammopharmacology       Date:  2021-05-18       Impact factor: 4.473

Review 4.  The Involvement of the Oxidative Stress Status in Cancer Pathology: A Double View on the Role of the Antioxidants.

Authors:  Kamal Fatima Zahra; Radu Lefter; Ahmad Ali; Ech-Chahad Abdellah; Constantin Trus; Alin Ciobica; Daniel Timofte
Journal:  Oxid Med Cell Longev       Date:  2021-08-05       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.